Covid-19 Around the Globe Update
First, for those who may have earlier missed it, here is a Worldometers site that gives a country by country statistical comparison of Covid-19 cases:
There is also this interactive map that focuses on such statistics for Africa:
Below are some country by country articles on the topic of vaccinations, including this first article that discusses effectiveness against mutant strains:
(Science) As potentially more dangerous coronavirus variants spread worldwide, scientists and clinicians have raced to discover how well the available COVID-19 vaccines protect against the mutant strains. Preliminary results from a large study of health care workers now suggest one dose of CoronaVac, a vaccine developed by a Chinese company, is still about 50% effective against symptomatic COVID-19 in a Brazilian city where more than three-fourths of new cases are caused by the highly transmissible variant known as P.1.
Although 50% effectiveness is far below the greater than 90% real-world protection of COVID-19 vaccines made with messenger RNA (mRNA), it may still be good enough to curb the disease’s spread within Brazil; vaccines with that level of efficacy in a clinical trial qualify for emergency use in many places and meet the World Health Organization’s threshold, as well.
…It’s also not clear how well the mRNA vaccines protect against the P.1 variant; their clinical tests happened before it was circulating or in places with little of the variant
(All Africa) South African Health Minister Zweli Mkhize has announced that the second phase of the country's vaccination rollout will begin on May 17, 2021. Mkhize added that the country secured a combined 51 million jabs in agreements that have been signed with various drug makers, aimed at 42 million people. According to Mkhize, 31 million jabs are from Johnson & Johnson, while 20 million will come from Pfizer.
The country is also expecting about 1.2 million vaccines from COVID-19 Vaccines Global Access (COVAX). As of April 9, 2021, 1,554,975 confirmed cases of Covid-19 have been recorded in the country of which 53,173 proved fatal and 1,480,632 resulted in the recovery. Vaccinations to date total 283,629.
(The Japan Times) Japan’s vaccination drive finally kicked into gear Monday around four months after the start of inoculations in the United States and the United Kingdom, a slow rollout that has generated further criticism of Prime Minister Yoshihide Suga’s handling of the pandemic.
The doses for people 65 and over are the first vaccinations for members of the public in Japan after priority was given to inoculating front-line medical staff first.
Japan has so far weathered the coronavirus pandemic relatively well, with infection numbers and deaths just a fraction of many Western countries. But the slow vaccination plan means struggling businesses and fearful shoppers will have to hold out for longer as the recovery of the economy is delayed by as much as two years compared with global peers.
The tardy start comes as stricter measures were reinstated today to quell an uptick in virus cases in the capital.
(The Indian Express) An expert panel of India’s central drug authority has recommended granting approval to Russian COVID-19 vaccine Sputnik V for emergency use in the country with certain conditions, sources said.
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) on Monday took up the application of Dr Reddy’s Laboratories seeking emergency use authorisation for Sputnik V..
The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
(The National)…the story of Bhutan’s vaccination campaign is nearly finished – just 16 days after it began.
The tiny Himalayan kingdom wedged between India and China has vaccinated nearly 93 per cent of its adult population since March 27.
Overall, the country has vaccinated 62 per cent of its 800,000 people.